Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Oehler

Showing results (61-70 of 107) with videos related to

Pageof 11
Sort By:
Blood Cancer Journal|April 11, 2015
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaborationJ C Huang, S K Basu, X Zhao, et al.
Current Cancer Drug Targets|December 17, 2010
The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cellsYong-Mi Kim, Hong Ma, Vivian G Oehler, et al.
Leukemia|October 1, 2025
Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axisTania Setiawan, Jabir Aliyu Muhammad, Nadya Marcellina, et al.
Leukemia|March 5, 2026
Correction: Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axisTania Setiawan, Jabir Aliyu Muhammad, Nadya Marcelina Julianto, et al.
Leukemia|July 11, 2008
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCRV G Oehler, J Qin, R Ramakrishnan, et al.
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Leukemia & Lymphoma|February 21, 2020
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasmRaffaele Palmieri, Sarah A Buckley, Megan Othus, et al.
Cell Stem Cell|July 28, 2015
Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous LeukemiaHyog Young Kwon, Jeevisha Bajaj, Takahiro Ito, et al.
Leukemia|January 23, 2026
Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncologyVivian G Oehler, Olga Sala-Torra, Neta Gilderman, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
Discovery of U2AF1 neoantigens in myeloid neoplasmsMelinda Ann Biernacki, Jessica Lok, Ralph Graeme Black, et al.
Pageof 11

Showing results (61-70 of 107) with videos related to

Sort By:
Pageof 11
Blood Cancer Journal|April 11, 2015
Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaborationJ C Huang, S K Basu, X Zhao, et al.
Current Cancer Drug Targets|December 17, 2010
The gamma catenin/CBP complex maintains survivin transcription in β-catenin deficient/depleted cancer cellsYong-Mi Kim, Hong Ma, Vivian G Oehler, et al.
Leukemia|October 1, 2025
Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axisTania Setiawan, Jabir Aliyu Muhammad, Nadya Marcellina, et al.
Leukemia|March 5, 2026
Correction: Regulation of metabolic adaptation and leukemia progression by MUSASHI2-DEPTOR-KIF11 axisTania Setiawan, Jabir Aliyu Muhammad, Nadya Marcelina Julianto, et al.
Leukemia|July 11, 2008
Absolute quantitative detection of ABL tyrosine kinase domain point mutations in chronic myeloid leukemia using a novel nanofluidic platform and mutation-specific PCRV G Oehler, J Qin, R Ramakrishnan, et al.
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Leukemia & Lymphoma|February 21, 2020
Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasmRaffaele Palmieri, Sarah A Buckley, Megan Othus, et al.
Cell Stem Cell|July 28, 2015
Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous LeukemiaHyog Young Kwon, Jeevisha Bajaj, Takahiro Ito, et al.
Leukemia|January 23, 2026
Next-generation sequencing from chronic myeloid leukemia dried blood spots: insights and implications for global oncologyVivian G Oehler, Olga Sala-Torra, Neta Gilderman, et al.
Journal for Immunotherapy of Cancer|January 2, 2024
Discovery of U2AF1 neoantigens in myeloid neoplasmsMelinda Ann Biernacki, Jessica Lok, Ralph Graeme Black, et al.
Pageof 11